Health
16 Oct 2026
Labcorp buys BioReference lab businesses in $872M deal
Labcorp will acquire selected BioReference assets for $722 million cash plus up to $150 million earnout, adding clinical, women’s health, urology and correctional testing and more than 80 service centers.
Read more